| . | N . |
|---|---|
| Sex | |
| Male | 11 |
| Female | 20 |
| Age (yr) | |
| Mean ± SD | 59.8 ± 16.3 |
| Median (range) | 64.0 (15–88) |
| Primary lesion | 31 |
| Tumor thickness | |
| <1.00 mm | 10 |
| 1.00–2.00 mm | 5 |
| 2.01–4.00 mm | 7 |
| >4.01 mm | 9 |
| Mean ± SD (mm) | 3.04 ± 2.89 |
| Median (range) | 2.10 (0.2–10.0) |
| Tumor subtype | |
| Acral lentiginous melanoma | 10 (32.3%) |
| Nodular melanoma | 11 (35.5%) |
| Superficial spreading melanoma | 9 (29.0%) |
| Lentigo maligna melanoma | 1 (3.2%) |
| TNM stage | |
| Stage I | 12 |
| Stage II | 9 |
| Stage III | 9 |
| Stage IV | 1 |
| . | N . |
|---|---|
| Sex | |
| Male | 11 |
| Female | 20 |
| Age (yr) | |
| Mean ± SD | 59.8 ± 16.3 |
| Median (range) | 64.0 (15–88) |
| Primary lesion | 31 |
| Tumor thickness | |
| <1.00 mm | 10 |
| 1.00–2.00 mm | 5 |
| 2.01–4.00 mm | 7 |
| >4.01 mm | 9 |
| Mean ± SD (mm) | 3.04 ± 2.89 |
| Median (range) | 2.10 (0.2–10.0) |
| Tumor subtype | |
| Acral lentiginous melanoma | 10 (32.3%) |
| Nodular melanoma | 11 (35.5%) |
| Superficial spreading melanoma | 9 (29.0%) |
| Lentigo maligna melanoma | 1 (3.2%) |
| TNM stage | |
| Stage I | 12 |
| Stage II | 9 |
| Stage III | 9 |
| Stage IV | 1 |